Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancer

• Hauptverfasser: Yves Denizot (Verfasst von), Véronique Truffinet (Verfasst von), Stéphane Bouvier (Verfasst von), Alain Gainant (Verfasst von), Pierre Cubertafond (Verfasst von), Muriel Mathonnet (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2004-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

This clinical study reports that blood levels of the pro-inflammatory mediator platelet-activating factor (PAF) did not change in colorectal cancer patients. In contrast, plasma levels of two enzymatic activities, one implicated in PAF production (i.e. phospholipase A2) and one in PAF degradation (i...